WEST PHARMACEUTICAL SERVICES, INC. Selling, General and Administrative Expense
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Selling, General and Administrative Expense of $117.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $117.60M, a 22.63% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $99.50M, a 13.07% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $107.00M, a 25.44% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $102.70M, a 22.99% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for fiscal 2025 was $393.60M, a 16.28% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for fiscal 2024 was $338.50M, a 4.22% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for fiscal 2023 was $353.40M, a 11.52% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. selling, general and administrative expense for fiscal 2022 was $316.90M, a 12.65% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $117.60M 10-Q · filed 2026-07-23 | $217.10M 10-Q · filed 2026-07-23 | $324.10M derived: sum of 3 quarters · filed 2026-07-23 | $426.80M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $99.50M 10-Q · filed 2026-04-23 | $206.50M derived: sum of 2 quarters · filed 2026-04-23 | $309.20M derived: sum of 3 quarters · filed 2026-04-23 | $405.10M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | $107.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $209.70M derived: sum of 2 quarters · filed 2026-02-17 | $305.60M derived: sum of 3 quarters · filed 2026-07-23 | $393.60M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $102.70M 10-Q · filed 2025-10-23 | $198.60M derived: sum of 2 quarters · filed 2026-07-23 | $286.60M 10-Q · filed 2025-10-23 | $371.90M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $95.90M 10-Q · filed 2026-07-23 | $183.90M 10-Q · filed 2026-07-23 | $269.20M derived: sum of 3 quarters · filed 2026-07-23 | $352.70M derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $88.00M 10-Q · filed 2026-04-23 | $173.30M derived: sum of 2 quarters · filed 2026-04-23 | $256.80M derived: sum of 3 quarters · filed 2026-04-23 | $339.80M derived: sum of 4 quarters · filed 2026-04-23 | ||||
| 2024-12-31 | $85.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $168.80M derived: sum of 2 quarters · filed 2026-02-17 | $251.80M derived: sum of 3 quarters · filed 2026-02-17 | $338.50M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $83.50M 10-Q · filed 2025-10-23 | $166.50M derived: sum of 2 quarters · filed 2025-10-23 | $253.20M 10-Q · filed 2025-10-23 | $343.20M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $83.00M 10-Q · filed 2025-07-24 | $169.70M 10-Q · filed 2025-07-24 | $259.70M derived: sum of 3 quarters · filed 2026-02-17 | $348.70M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $86.70M 10-Q · filed 2025-04-24 | $176.70M derived: sum of 2 quarters · filed 2026-02-17 | $265.70M derived: sum of 3 quarters · filed 2026-02-17 | $354.10M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $179.00M derived: sum of 2 quarters · filed 2026-02-17 | $267.40M derived: sum of 3 quarters · filed 2026-02-17 | $353.40M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $89.00M 10-Q · filed 2024-10-24 | $177.40M derived: sum of 2 quarters · filed 2024-10-24 | $263.40M 10-Q · filed 2024-10-24 | $349.10M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $88.40M 10-Q · filed 2024-07-25 | $174.40M 10-Q · filed 2024-07-25 | $260.10M derived: sum of 3 quarters · filed 2025-02-18 | $326.40M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $86.00M 10-Q · filed 2024-04-25 | $171.70M derived: sum of 2 quarters · filed 2025-02-18 | $238.00M derived: sum of 3 quarters · filed 2025-02-18 | $319.50M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $85.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $152.00M derived: sum of 2 quarters · filed 2025-02-18 | $233.50M derived: sum of 3 quarters · filed 2025-02-18 | $316.90M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $66.30M 10-Q · filed 2023-10-26 | $147.80M derived: sum of 2 quarters · filed 2023-10-26 | $231.20M 10-Q · filed 2023-10-26 | $329.20M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $81.50M 10-Q · filed 2023-07-27 | $164.90M 10-Q · filed 2023-07-27 | $262.90M derived: sum of 3 quarters · filed 2024-02-20 | $354.80M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $83.40M 10-Q · filed 2023-04-27 | $181.40M derived: sum of 2 quarters · filed 2024-02-20 | $273.30M derived: sum of 3 quarters · filed 2024-02-20 | $366.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $189.90M derived: sum of 2 quarters · filed 2024-02-20 | $282.60M derived: sum of 3 quarters · filed 2024-02-20 | $362.80M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $91.90M 10-Q · filed 2022-10-27 | $184.60M derived: sum of 2 quarters · filed 2022-10-27 | $264.80M 10-Q · filed 2022-10-27 | $341.10M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $92.70M 10-Q · filed 2022-07-28 | $172.90M 10-Q · filed 2022-07-28 | $249.20M derived: sum of 3 quarters · filed 2023-02-21 | $325.40M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $80.20M 10-Q · filed 2022-04-28 | $156.50M derived: sum of 2 quarters · filed 2023-02-21 | $232.70M derived: sum of 3 quarters · filed 2023-02-21 | $310.40M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $76.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $152.50M derived: sum of 2 quarters · filed 2023-02-21 | $230.20M derived: sum of 3 quarters · filed 2023-02-21 | $302.00M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $76.20M 10-Q · filed 2021-10-28 | $153.90M derived: sum of 2 quarters · filed 2021-10-28 | $225.70M 10-Q · filed 2021-10-28 | $294.70M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $77.70M 10-Q · filed 2021-07-30 | $149.50M 10-Q · filed 2021-07-30 | $218.50M derived: sum of 3 quarters · filed 2022-02-22 | $283.30M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $71.80M 10-Q · filed 2021-04-30 | $140.80M derived: sum of 2 quarters · filed 2022-02-22 | $205.60M derived: sum of 3 quarters · filed 2022-02-22 | $275.90M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $133.80M derived: sum of 2 quarters · filed 2022-02-22 | $204.10M derived: sum of 3 quarters · filed 2022-02-22 | $272.70M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $64.80M 10-Q · filed 2020-10-23 | $135.10M derived: sum of 2 quarters · filed 2020-10-23 | $203.70M 10-Q · filed 2020-10-23 | $263.40M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $70.30M 10-Q · filed 2020-07-24 | $138.90M 10-Q · filed 2020-07-24 | $198.60M derived: sum of 3 quarters · filed 2021-02-23 | $263.50M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $68.60M 10-Q · filed 2020-04-24 | $128.30M derived: sum of 2 quarters · filed 2021-02-23 | $193.20M derived: sum of 3 quarters · filed 2021-02-23 | $263.20M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $59.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $124.60M derived: sum of 2 quarters · filed 2021-02-23 | $194.60M derived: sum of 3 quarters · filed 2021-02-23 | $262.90M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $64.90M 10-Q · filed 2019-10-29 | $134.90M derived: sum of 2 quarters · filed 2019-10-29 | $203.20M 10-Q · filed 2019-10-29 | $262.80M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $70.00M 10-Q · filed 2019-07-29 | $138.30M 10-Q · filed 2019-07-29 | $197.90M derived: sum of 3 quarters · filed 2020-02-24 | $260.50M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $68.30M 10-Q · filed 2019-05-08 | $127.90M derived: sum of 2 quarters · filed 2020-02-24 | $190.50M derived: sum of 3 quarters · filed 2020-02-24 | $251.80M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $59.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $122.20M derived: sum of 2 quarters · filed 2020-02-24 | $183.50M derived: sum of 3 quarters · filed 2020-02-24 | $246.00M 10-K · filed 2020-02-24 | $242.60M 10-K · filed 2018-02-26 | |||
| 2017-09-30 | $62.60M 10-Q · filed 2018-10-30 | $61.50M 10-Q · filed 2017-10-31 | $123.90M derived: sum of 2 quarters · filed 2018-10-30 | $186.40M 10-Q · filed 2018-10-30 | $183.70M 10-Q · filed 2017-10-31 | $247.10M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $61.30M 10-Q · filed 2018-07-31 | $60.60M 10-Q · filed 2017-08-01 | $123.80M 10-Q · filed 2018-07-31 | $122.20M 10-Q · filed 2017-08-01 | $184.50M derived: sum of 3 quarters · filed 2019-02-28 | $242.80M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $62.50M 10-Q · filed 2018-05-08 | $61.60M 10-Q · filed 2017-05-05 | $123.20M derived: sum of 2 quarters · filed 2019-02-28 | $181.50M derived: sum of 3 quarters · filed 2019-02-28 | $244.00M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $60.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $119.00M derived: sum of 2 quarters · filed 2019-02-28 | $181.50M derived: sum of 3 quarters · filed 2019-02-28 | $239.60M 10-K · filed 2019-02-28 | $239.80M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $58.30M 10-Q · filed 2017-10-31 | $120.80M derived: sum of 2 quarters · filed 2017-10-31 | $178.90M 10-Q · filed 2017-10-31 | $241.30M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $62.50M 10-Q · filed 2017-08-01 | $120.60M 10-Q · filed 2017-08-01 | $183.00M derived: sum of 3 quarters · filed 2018-02-26 | $237.60M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $58.10M 10-Q · filed 2017-05-05 | $120.50M derived: sum of 2 quarters · filed 2018-02-26 | $175.10M derived: sum of 3 quarters · filed 2018-02-26 | $235.90M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $62.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $117.00M derived: sum of 2 quarters · filed 2018-02-26 | $177.80M derived: sum of 3 quarters · filed 2018-02-26 | $233.00M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $54.60M 10-Q · filed 2016-10-31 | $115.40M derived: sum of 2 quarters · filed 2016-10-31 | $170.60M 10-Q · filed 2016-10-31 | $229.40M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $60.80M 10-Q · filed 2016-08-01 | $116.00M 10-Q · filed 2016-08-01 | $174.80M derived: sum of 3 quarters · filed 2017-02-28 | $230.80M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $55.20M 10-Q · filed 2016-05-06 | $114.00M derived: sum of 2 quarters · filed 2017-02-28 | $170.00M derived: sum of 3 quarters · filed 2017-02-28 | $227.50M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $58.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $114.80M derived: sum of 2 quarters · filed 2017-02-28 | $172.30M derived: sum of 3 quarters · filed 2017-02-28 | $228.70M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $56.00M 10-Q · filed 2015-11-02 | $113.50M derived: sum of 2 quarters · filed 2015-11-02 | $169.90M 10-Q · filed 2015-11-02 | $229.90M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $57.50M 10-Q · filed 2015-08-03 | $113.90M 10-Q · filed 2015-08-03 | $173.90M derived: sum of 3 quarters · filed 2016-02-26 | $230.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $56.40M 10-Q · filed 2015-05-06 | $116.40M derived: sum of 2 quarters · filed 2016-02-26 | $172.50M derived: sum of 3 quarters · filed 2016-02-26 | $232.20M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $116.10M derived: sum of 2 quarters · filed 2016-02-26 | $175.80M derived: sum of 3 quarters · filed 2016-02-26 | $234.90M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $56.10M 10-Q · filed 2014-11-03 | $115.80M derived: sum of 2 quarters · filed 2014-11-03 | $174.90M 10-Q · filed 2014-11-03 | $233.50M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $59.70M 10-Q · filed 2014-08-01 | $118.70M 10-Q · filed 2014-08-01 | $177.40M derived: sum of 3 quarters · filed 2015-02-25 | $231.10M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $59.10M 10-Q · filed 2014-05-08 | $117.70M derived: sum of 2 quarters · filed 2015-02-25 | $171.40M derived: sum of 3 quarters · filed 2015-02-25 | $225.80M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $58.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $112.30M derived: sum of 2 quarters · filed 2015-02-25 | $166.70M derived: sum of 3 quarters · filed 2015-02-25 | $218.10M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | $53.70M 10-Q · filed 2013-11-04 | $108.10M derived: sum of 2 quarters · filed 2013-11-04 | $159.50M 10-Q · filed 2013-11-04 | $207.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $54.40M 10-Q · filed 2013-08-05 | $105.70M 10-Q · filed 2013-08-05 | $154.10M derived: sum of 3 quarters · filed 2014-02-27 | $199.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $51.30M 10-Q · filed 2013-05-06 | $99.70M derived: sum of 2 quarters · filed 2014-02-27 | $145.40M derived: sum of 3 quarters · filed 2014-02-27 | $191.80M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $48.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $94.10M derived: sum of 2 quarters · filed 2014-02-27 | $140.50M derived: sum of 3 quarters · filed 2014-02-27 | $191.10M 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $45.70M 10-Q · filed 2012-11-05 | $92.10M derived: sum of 2 quarters · filed 2012-11-05 | $142.70M 10-Q · filed 2012-11-05 | $144.80M 10-Q · filed 2011-11-07 | $193.20M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-30 | $46.40M 10-Q · filed 2012-08-06 | $48.50M 10-Q/A · filed 2011-08-08 | $97.10M 10-Q · filed 2012-08-06 | $99.20M 10-Q/A · filed 2011-08-08 | $147.50M derived: sum of 3 quarters · filed 2013-02-27 | $192.40M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | $50.60M 10-Q · filed 2012-05-04 | $101.10M derived: sum of 2 quarters · filed 2013-02-27 | $146.00M derived: sum of 3 quarters · filed 2013-02-27 | $191.80M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $50.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $95.40M derived: sum of 2 quarters · filed 2013-02-27 | $141.20M derived: sum of 3 quarters · filed 2013-02-27 | $187.70M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $44.90M 10-Q · filed 2011-11-07 | $90.70M derived: sum of 2 quarters · filed 2011-11-07 | $137.20M 10-Q · filed 2011-11-07 | $182.70M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-06-30 | $45.80M 10-Q/A · filed 2011-08-08 | $92.40M 10-Q/A · filed 2011-08-08 | $137.80M derived: sum of 3 quarters · filed 2012-03-01 | $182.10M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2010-03-31 | $46.60M 10-Q · filed 2011-05-05 | $92.00M derived: sum of 2 quarters · filed 2012-03-01 | $136.30M derived: sum of 3 quarters · filed 2012-03-01 | $181.40M derived: sum of 4 quarters · filed 2012-03-01 | ||||
| 2009-12-31 | $45.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $89.70M derived: sum of 2 quarters · filed 2012-03-01 | $134.80M derived: sum of 3 quarters · filed 2012-03-01 | $177.70M 10-K/A · filed 2012-03-01 | ||||
| 2009-09-30 | $44.30M 10-Q · filed 2010-11-05 | $89.40M derived: sum of 2 quarters · filed 2010-11-05 | $132.30M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $45.10M 10-Q · filed 2010-08-05 | $88.00M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $159.30M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |